ProCE Banner Activity

The Evolving Role of TKIs in First-line Treatment of Advanced HCC

Podcast Episodes
In this podcast episode, experts Josep M. Llovet, MD, PhD, and Univ. Prof. Markus Peck-Radosavljevic, MD, MBA, discuss the evolving role of tyrosine kinase inhibitors in the first-line treatment of patients with advanced hepatocellular carcinoma.

Released: December 14, 2021

Expiration: December 13, 2022

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by an educational grant from

Bayer Healthcare Pharma